Wuhan Easy Diagnosis BiomedicineLtd Management
Management criteria checks 3/4
Wuhan Easy Diagnosis BiomedicineLtd's CEO is Chen Li Li, appointed in Oct 2013, has a tenure of 11.17 years. directly owns 30.57% of the company’s shares, worth CN¥1.27B. The average tenure of the management team and the board of directors is 11.2 years and 2.2 years respectively.
Key information
Chen Li Li
Chief executive officer
CN¥600.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.2yrs |
| CEO ownership | 30.6% |
| Management average tenure | 11.2yrs |
| Board average tenure | 2.2yrs |
Recent management updates
CEO
Chen Li Li (50 yo)
11.2yrs
Tenure
CN¥600,000
Compensation
Ms. Chen Li Li is Chairman and General Manager of Wuhan Easy Diagnosis Biomedicine Co.,Ltd. She joined the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. on October 23, 2013.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 11.2yrs | CN¥600.00k | 30.57% CN¥ 1.3b | |
| Vice Chairman & Deputy GM | no data | CN¥600.00k | 16.11% CN¥ 671.6m | |
| Financial Manager | 3.3yrs | CN¥504.00k | no data | |
| Deputy GM & Board Secretary | no data | CN¥700.00k | 1.36% CN¥ 56.6m |
11.2yrs
Average Tenure
48yo
Average Age
Experienced Management: 002932's management team is seasoned and experienced (11.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥600.00k | 30.57% CN¥ 1.3b | |
| Vice Chairman & Deputy GM | no data | CN¥600.00k | 16.11% CN¥ 671.6m | |
| Independent Director | 2.2yrs | CN¥50.00k | no data | |
| Employee Member of the Supervisory Board | no data | no data | no data | |
| Member of the Supervisory Board | no data | no data | no data | |
| Non-Independent Director | no data | CN¥120.00k | no data | |
| Independent Director | 2.2yrs | CN¥50.00k | no data | |
| Independent Director | 2.2yrs | CN¥50.00k | no data |
2.2yrs
Average Tenure
50yo
Average Age
Experienced Board: 002932's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 17:41 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|